Related Experiment Videos
[Long-term follow up of patients with pernicious anemia]
Insights
This study analyzed 357 megaloblastic anemia patients, primarily pernicious anemia, over 30 years. Findings detail patient demographics, disease patterns, and associations with autoimmune conditions and cancers.
Area of Science:
- Hematology
- Internal Medicine
- Clinical Research
Context:
- Megaloblastic anemia, particularly pernicious anemia, presents diagnostic and management challenges.
- Longitudinal data from a significant patient cohort (n=357) over three decades provides valuable insights.
- Understanding disease characteristics and associations is crucial for patient care.
Purpose:
- To present comprehensive data on megaloblastic anemia cases diagnosed and treated between 1958-1988.
- To analyze demographic, clinical, and etiological factors associated with megaloblastic anemia.
- To investigate the relationship between megaloblastic anemia and other autoimmune diseases and malignant tumors.
Summary:
- The study details 357 megaloblastic anemia cases, with 334 diagnosed with pernicious anemia and 23 with postresectional megaloblastic anemia.
- Data includes patient demographics (age, sex, blood groups), incidence, relapse rates, and familial aggregation.
- Associations with autoimmune diseases and malignant tumors, notably stomach carcinoma, were examined.
Impact:
- Provides a detailed epidemiological profile of megaloblastic anemia over a 30-year period.
- Highlights the comorbidity of megaloblastic anemia with autoimmune disorders and increased cancer risk.
- Informs clinical practice regarding diagnosis, management, and long-term surveillance of megaloblastic anemia patients.
Abstract:
The authors give several data of 357 patients with megaloblastic anaemia diagnosed, treated and controlled between 1958-1988. 334 of the patients had anaemia perniciosa and 23 of them had postresectional megaloblastic anaemia. After listing the criteria of the diagnosis the authors detail the mean age of the patients at the time of diagnosis, the distribution of sexes, age and blood groups among the patients, the number of new cases per year, the frequency of relapsus of the disease and its association with other autoimmune diseases. They also deal with the characteristic seasonal fluctuation and the accumulated cases in families. Its association with malignant tumours, especially with stomach carcinoma was examined.